The founder of AIT Laboratories, along with his insurance companies and bank, will pay back more than $3 million to employees who bought the company from him six years ago at what the government said was an inflated price.
It’s been a roller-coaster ride for Indiana physicians and hospitals, with fees swinging wildly up and down in recent years to fund a state insurance program that helps pay malpractice awards.
The Indiana Blood Center said it has been forced to defer up to 30 percent of donors at some post-spring break blood drives because they had traveled to areas where the Zika virus is being transmitted.
A federal judge made the award to Lilly’s former executive director of human resources, who quit for health reasons and was later dropped from the company’s extended disability plan.
An analyst said the delay could be a sign of trouble for the acquisition.
Humana Inc. is set to exit Obamacare markets in at least two states to stem financial losses, another sign of the struggles that health insurers face in the controversial program.
Indianapolis-based chemical manufacturer Vertellus Specialties Inc. has expanded its production capacity by 80 percent to keep up with customer demand for DEET, a common active ingredient in mosquito and tick repellents.
During his tenure, Wayne DeVeydt helped Anthem navigate through the recession, make the transition into Obamacare and negotiate its planned $54 billion acquisition of rival Cigna Corp.
It’s the largest recall in recent years for Cook, which previously had issued four recalls covering more than 400,000 catheters and pressuring monitoring sets in the past two years.
PTS Diagnostics, with about 150 employees in Indianapolis, said Monday it has entered a definitive agreement to be acquired by China-based Sinocare Inc.
Drugmaker Pfizer Inc. agreed to pay a total of $785 million to resolve allegations that one of its companies didn't give Medicaid the same discounts it provided to private purchasers of the heartburn treatment Protonix.
Carmel-based Mainstreet Property Group is suing the Indiana State Department of Health in a legal challenge to the state’s new moratorium on nursing homes and transitional care properties.
CNO Financial Group Inc. on Wednesday reported quarterly results that fell short of Wall Street predictions.
Seven insurers, including Indianapolis-based Anthem Inc., reached an agreement with New York Attorney General Eric Schneiderman to cover hepatitis C drugs for patients in the early stages of the disease and for drug and alcohol users.
The Indianapolis-based insurer essentially broke even on its Obamacare exchange business last year.
Lilly got a boost from a stable of new drugs but saw sales tumble for longtime stalwarts Cymbalta and Humalog. Meanwhile, R&D costs rose as the company ushered products through its late-stage pipeline.
Bristol-Myers Squibb Co.’s blockbuster cancer drug Opdivo prolonged survival in cases of recurrent head and neck cancer, a first for patients with the harshest form of the disease who often face a bleak prognosis.
UnitedHealth Group Inc., the biggest U.S. health insurer, said it expects to lose about $650 million on the Obamacare plans this year.
The Carmel-based company has a hired a president and promoted longtime exec Erik Helding to chief financial officer. The company also announced the departure of its chief business officer.
The nation’s biggest health insurer has decided to stop selling coverage on public insurance exchanges in two states next year and is continuing to evaluate its presence in other markets after reporting steep losses.
